A Multicenter Study to Evaluate the Cios Spin and the Ion Endoluminal System for Pulmonary Nodule Biopsy

Study summary

The overall objective of this study is to evaluate procedure characteristics of pulmonary nodule biopsies using the integrated version of Cios Spin and the Ion Endoluminal System.

Ask AI to explain this study

Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedIon Endoluminal System and Cios Spin

The study team can explain what participation involves.

Who it may be forLung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Nov 13, 2025 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Observational

Where is it offered?6 U.S. locations

Locations may change over time.

Who runs it?Intuitive Surgical

Study sponsor

Study overview

What this study is about

Purpose: Not specified
Study type: Observational
Phase: Not applicable
Sponsor: Intuitive Surgical
Interventions being studied: Device: Ion Endoluminal System and Cios Spin

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Subject is 18 years or older at the time of the procedure.
Pulmonary nodule biopsy attempted/performed using the Ion Endoluminal System and Cios Spin 3D imaging.
Pulmonary nodule ≤2 cm in largest diameter.
Subject able to understand and adhere to study requirements and provide informed consent.

Reasons someone may not be able to joinExclusion criteria

Planned lymph node staging performed before nodule biopsy.
Nodule is a pure ground glass opacity.
Plan to biopsy multiple nodules.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

University of Alabama at BirminghamBirmingham, Alabama
University of California San Diego, Hillcrest Medical CenterSan Diego, California
Mayo Clinic - RochesterRochester, Minnesota
Memorial Sloan Kettering Cancer CenterNew York, New York
South Austin HospitalAustin, Texas
MD Anderson Cancer CenterHouston, Texas

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Nov 13, 2025. Always confirm current availability with the study team.

View original record ↗